RED FRANCO ARGENTINA PARA EL CÁNCER DE PÁNCREAS; MONTE, MARTIN

The mRNA vaccine for the treatment of pancreatic cancer is here to stay

MEDICINA (BUENOS AIRES); Año: 2023

PASCUCCI, FRANCO ANDRÉS; ESCALADA, MICAELA CAROLINA; SUBERBORDES, MELISA; VIDAL, CANDELA; LADELFA, MARÍA FÁTIMA; MONTE, MARTÍN

MAGE-I proteins and cancer-pathways: A bidirectional relationship

BIOCHIMIE; Año: 2022

GISELA I. MAZAIRA; ; PABLO ECHEVERRIA; SOL CIUCCI; MARTIN MONTE; LUCIANA GALLO; ALEJANDRA ERLEJMAN; MARIO GALIGNIANA

Differential regulation of the glucocorticoid receptor nucleocytoplasmic shuttling by TPR-domain proteins

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH; Lugar: Amsterdam; Año: 2021

LADELFA MF; PECHE LY; AMATO G; ESCALADA, MICAELA; ZAMPIERI S; PASCUCCI, FRANCO; FERNANDEZ BENEVENTO A; DO PORTO D; DARDIS A; SCHNEIDER C; MONTE M

Expression of the tumor-expressed protein MageB2 enhances rRNA transcription

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH; Lugar: Amsterdam; Año: 2021

PASCUCCI, FRANCO; LADELFA, FATIMA; TOLEDO, M FERNANDA; ESCALADA, MICAELA; SUBERBORDES, MELISA; MONTE, MARTIN

MageC2 protein is upregulated by oncogenic activation of MAPK pathway and causes impairment of the p53 transactivation function

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH; Lugar: Amsterdam; Año: 2020

GIOVANNONI, FEDERICO; LADELFA, MARÍA FATIMA; MONTE, MARTIN; JANS, DAVID A.; HEMMERICH, PETER; GARCÍA, CYBELE

Dengue Non-structural Protein 5 Polymerase Complexes With Promyelocytic Leukemia Protein (PML) Isoforms III and IV to Disrupt PML-Nuclear Bodies in Infected Cells

Frontiers in Cellular and Infection Microbiology; Año: 2019 vol. 9

JULIETA LAISECA; MARIA FATIMA LADELFA; JAVIER COTIGNOLA; FRANCO PASCUCCI; BRYAN CASTAÑO; MARIO D. GALIGNIANA.; CLAUDIO SCHNEIDER; MARTIN MONTE

Functional interaction between co-expressed MAGE-A proteins

PLOS ONE; Lugar: San Francisco; Año: 2017 vol. 12

MONTE, MARTIN

Descubrimiento de las propiedades oncogénicas de los antígenos MAGE

QUíMICA VIVA; Año: 2017

DEBORA STELITANO; LETICIA PECHE; EMILIANO DALLA; MARTIN MONTE; SILVANO PIAZZA; CLAUDIO SCHNEIDER

GTSE1: a novel TEAD4-E2F1 target gene involved in cell protrusions formation in Triple Negative Breast Cancer

Oncotarget; Año: 2017

JULIETA LAISECA; FRANCO PASCUCCI; MARTIN MONTE; MARIA FATIMA LADELFA

Regulation of transcription factors by tumor-specific MAGE proteins

Journal of Biochemistry and Molecular Biology Research; Año: 2015 vol. 1 p. 118 - 122

LETICIA PECHE; MARIA FATIMA LADELFA; MARIA FERNANDA TOLEDO; MIGUEL MANO; JULIETA LAISECA; CLAUDIO SCHNEIDER; MARTIN MONTE

Human MageB2 Expression Enhances E2F Activity, Cell Proliferation And Resistance To Ribotoxic Stress

JOURNAL OF BIOLOGICAL CHEMISTRY; Lugar: Bethesda, Maryland; Año: 2015

LAISECA, JULIETA; PASCUCCI, FRANCO; MARTIN MONTE; LADELFA, FATIMA

Regulation of Transcription Factors by Tumor-Specific MAGE Proteins

Journal of Biochemistry and Molecular Biology Research; Año: 2015 vol. 4 p. 118 - 122

20. M.F.LADELFA, L.Y.PECHE, M.F. TOLEDO, J.E. LAISECA, C.SCHNEIDER, M. MONTE

Tumor-specific MAGE proteins as regulators of p53

CANCER LETTERS; Lugar: Amsterdam; Año: 2012 vol. 325 p. 11 - 17

SCOLZ M; WIDLUND P; PIAZZA S; BUBLIK DR; REBER S; PECHE LY; CIANI; HUBNER N; ISOKANE M; MONTE M; ELLENBERG J; HYMAN AA; SCHNEIDER C; BIRD AW

GTSE1 is a Microtubule Plus-end Tracking Protein that Regulates EB1-dependent Cell Migration

PLOS ONE; Lugar: San Francisco; Año: 2012 vol. 7 p. 51259 - 51265

M. SEILLIER, S. PEUGET, O. GAYET, C.GAUTHIER, P.N'GUESSAN, M. MONTE, A.CARRIER, J.L.IOVANNA, N.DUSETTI

TP53INP1, a tumor suppressor, interacts with LC3 and ATG8-family proteins through the LC3-interacting region (LIR) and promotes autophagic cell death

CELL DEATH AND DIFFERENTIATION; Lugar: Londres; Año: 2012 vol. 19 p. 1525 - 1535

LETICIA PECHE; SCOLZ M; LADELFA MF; MONTE M; CLAUDIO SCHNEIDER

Mage-A2 restrains cellular senescence by targeting the function of PMLV/p53 function at the PML-NBs

CELL DEATH AND DIFFERENTIATION; Año: 2012 p. 926 - 936

M.F. LADELFA, M.F. TOLEDO, J.E LAISECA, M. MONTE

Interaction of p53 with tumor suppressive and oncogenic signaling pathways to control cellular ROS production

ANTIOXIDANTS & REDOX SIGNALING; Año: 2011 vol. 15 p. 1749 - 1761

M.D.GALIGNIANA, A.ERLEJMAN, M MONTE, C. GOMEZ SANCHEZ, G. PIWIEN PILIPUK

The hsp90-FKBP52 complex links the mineralocorticoid receptor to motor proteins and persists bound to the receptor in early nuclear events

MOLECULAR AND CELLULAR BIOLOGY; Año: 2010 p. 1285 - 1298

GALIGNIANA MD; ERLEJMAN, AG; MONTE, M; GOMEZ SANCHEZ, C; PIWIEN PILIPUK, G

The hsp90-FKBP52 complex links the mineralocorticoid receptor to motor proteins and persists bound to the receptor in early nuclear events

MOLECULAR AND CELLULAR BIOLOGY; Año: 2010 vol. 35 p. 1285 - 1298

D.R. BUBLIK, M. SCOLZ, G.TRIOLO, M. MONTE, SCHNEIDER C

Human GTSE-1 regulates p21CIP1/WAF1 stability conferring resistance to placlitaxel treatment

JOURNAL OF BIOLOGICAL CHEMISTRY; Año: 2010 p. 5274 - 5281

MONTE M; SIMONATTO M; PECHE LY; BUBLIK DR; GOBESSI S; PIEROTTI MA; RODOLFO M; SCHNEIDER C

MAGE-A tumor antigens target p53 transactivation function through histone

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA; Lugar: USA; Año: 2006 vol. 103 p. 11160 - 11165

R. BENETTI, T. COPETTI, S. DELL’ORSO, E. MELLONI, C. BRANCOLINI, M. MONTE, C. SCHNEIDER

The calpain-system is involved in the constitutive regulation of beta-catenin signalling functions

JOURNAL OF BIOLOGICAL CHEMISTRY; Lugar: USA; Año: 2005 vol. 280 p. 22070 - 22080

M. MONTE, R. BENETTI, L.COLLAVIN, G. DEL SAL AND C. SCHNEIDER

hGTSE-1 expression stimulates cytoplasmic localization of p53

JOURNAL OF BIOLOGICAL CHEMISTRY; Lugar: USA; Año: 2004 vol. 279 p. 11744 - 11752

M. MONTE, R. BENETTI, G. BUSCEMI, P. SANDY, G. DEL SAL AND C. SCHNEIDER

The cell-cycle regulated protein human GTSE-1 controls DNA-damage induced apoptosis by affecting p53 function

JOURNAL OF BIOLOGICAL CHEMISTRY; Lugar: USA; Año: 2003 vol. 287 p. 30356 - 30364

E. AGOSTONI, S. GOBESSI, E. PETRINI, M. MONTE AND C. SCHNEIDER

Cloning and characterization of the C.elegans gas1 homologue: phas-1

BIOCHIMICA ET BIOPHYSICA ACTA, N. GENE STRUCTURE AND EXPRESSION; Lugar: USA; Año: 2002 vol. 1574 p. 1 - 9

. BENETTI, G. DEL SAL, M. MONTE, G. PARONI, C. BRANCOLINI AND C. SCHNEIDER

The death substrate Gas2 binds m-calpain and increases susceptibility to p53-dependent apoptosis

EMBO JOURNAL; Lugar: England; Año: 2001 vol. 20 p. 2702 - 2714

M. MONTE, L. COLLAVIN, D. LAZAREVIC, R. UTRERA, T.A. DRAGANI AND C. SCHNEIDER

Cloning, chromosome mapping and functional characterization of a human homologue of murine Gtse-1 (B99) gene

GENE; Lugar: Netherlands; Año: 2000 vol. 254 p. 229 - 236

COLLAVIN, M. MONTE, R. VERARDO C. PFLEGER, C. SCHNEIDER

Cell-cycle regulation of the p53-inducible gene B99

FEBS LETTERS; Lugar: Netherlands; Año: 2000 vol. 481 p. 57 - 62

L. COLLAVIN, D. LAZAREVIC, R. UTRERA, S. MARZINOTTO, M. MONTE, C. SCHNEIDER

wt-p53 dependent expression of a membrane-associated isoform of adenylate kinase

ONCOGENE; Lugar: England; Año: 1999 vol. 18 p. 5879 - 5888

: M. MONTE, L. DAVEL AND E. SACERDOTE DE LUSTIG

Hydrogen peroxide is involved in lymphocyte activation mechanisms to induce angiogenesis

EUROPEAN JOURNAL OF CANCER; Lugar: England; Año: 1997 vol. 33 p. 676 - 682

M. MONTE AND E. SACERDOTE DE LUSTIG

radicals of oxygen and superoxide dismutase. Biological and medical aspects

MEDICINA (BUENOS AIRES); Lugar: Buenos Aires; Año: 1994 vol. 54 p. 61 - 68

M. A. JASNIS, S. KLEIN, M. MONTE, L. DAVEL, E. SACERDOTE DE LUSTIG, AND I. D. ALGRANAT

Polyamines prevent DFMO-mediated inhibition of angiogenesis

CANCER LETTERS; Lugar: Ireland; Año: 1994 vol. 79 p. 39 - 43

M. MONTE, L. DAVEL AND E. SACERDOTE DE LUSTIG

Inhibition of lymphocyte-induced angiogenesis by free radical scavengers

FREE RADICAL BIOLOGY AND MEDICINE; Lugar: USA; Año: 1994 vol. 17 p. 259 - 266

1. M. MONTE, S. KLEIN, M. A. JASNIS, L. DAVEL, I. D. ALGRANATI AND E. SACERDOTE DE LUSTIG

Inhibition of lymphocyte and tumor-induced angiogenesis by the administration of difluoromethylornithine

CANCER JOURNAL; Lugar: USA; Año: 1993 vol. 6 p. 147 - 150